EC Number   |
Substrates |
Organism |
Products |
Reversibility |
|---|
  3.4.23.50 | 2-aminobenzoyl-Ala-Thr-His-Gln-Val-Tyr-Phe(NO2)-Val-Arg-Lys-Ala + H2O |
- |
Homo sapiens |
? |
- |
? |
| 3.4.23.50 | 2-aminobenzoyl-ATHQVY-(4-nitro)FVRKA + H2O |
- |
Homo sapiens |
2-aminobenzoyl-ATHQVY + (4-nitro)FVRKA |
- |
? |
| 3.4.23.50 | Gag polyprotein + H2O |
the enzyme is synthesized as part of the Gag polyprotein or the Gag-Pol polyprotein and autolytically processed to the mature dimer |
Homo sapiens |
? |
- |
? |
| 3.4.23.50 | Gag-Pol polyprotein + H2O |
the enzyme is synthesized as part of the Gag polyprotein or the Gag-Pol polyprotein and autolytically processed to the mature dimer |
Homo sapiens |
? |
- |
? |
| 3.4.23.50 | HERV-K Gag polyprotein + H2O |
- |
Homo sapiens |
? |
- |
? |
| 3.4.23.50 | HERV-K Gag polyprotein + H2O |
processing of HERV-K Gag is dependent on the presence of the functional retroviral protease |
Homo sapiens |
? |
HERV-K Gag is processed into matrix protein, a short spacer peptide, p15, capsid and nucelocapsid |
? |
| 3.4.23.50 | HIV-1 matrix-capsid polyprotein + H2O |
processing at the authentic HIV-1 PR recognition site |
Homo sapiens |
? |
- |
? |
| 3.4.23.50 | HIV-1 matrix-capsid polyprotein + H2O |
cleavage also in presence of HIV-1 PR inhibitor |
Homo sapiens |
? |
- |
? |
| 3.4.23.50 | KARVY-(4-nitro)FEA-Nle-NH2 + H2O |
- |
Homo sapiens |
KARVY + (4-nitro)FEA-Nle-NH2 |
- |
? |
| 3.4.23.50 | Lys-Ala-Arg-Val-Tyr-Phe(NO2)-Glu-Ala-Nle-NH2 + H2O |
- |
Homo sapiens |
? |
- |
? |
